The Telmisartan Market is driven by rising prevalence of hypertension
The Global Telmisartan Market is estimated to be valued at US$ 4.20 Bn in 2024 and is expected to exhibit a CAGR of 3.7% over the forecast period 2024 to 2031.
Telmisartan Market Growth burden of hypertension worldwide is driving significant for antihypertensive drugs like Telmisartan. As per the World Health Organization, hypertension currently affects over 1.13 billion people globally and is a major risk factor for heart attacks, strokes, kidney failure and other cardiovascular and metabolic diseases. increased awareness and screening for hypertension, coupled with higher diagnosis and treatment rates is expected to propel the growth of the Telmisartan market.
Telmisartan Market- https://prachicmi.liveposi...
#CoherentMarketInsights #SingleCompositionDrugs #HypertensionManagement #StrokePrevention #TelmisartanTablets
The Global Telmisartan Market is estimated to be valued at US$ 4.20 Bn in 2024 and is expected to exhibit a CAGR of 3.7% over the forecast period 2024 to 2031.
Telmisartan Market Growth burden of hypertension worldwide is driving significant for antihypertensive drugs like Telmisartan. As per the World Health Organization, hypertension currently affects over 1.13 billion people globally and is a major risk factor for heart attacks, strokes, kidney failure and other cardiovascular and metabolic diseases. increased awareness and screening for hypertension, coupled with higher diagnosis and treatment rates is expected to propel the growth of the Telmisartan market.
Telmisartan Market- https://prachicmi.liveposi...
#CoherentMarketInsights #SingleCompositionDrugs #HypertensionManagement #StrokePrevention #TelmisartanTablets
02:29 PM - Feb 07, 2025 (UTC)
